Maximal Rate of Force Development of Ankle Muscles and Functional Ability in Patients With Knee Osteoarthritis
Assessment of Maximal Rate of Force Development of Ankle Muscles and Its Association Functional Ability in Patients With Knee Osteoarthritis
1 other identifier
observational
126
1 country
1
Brief Summary
This study is a detailed assessment of the maximal rate of force development of ankle muscles and its association with functional ability in patients with knee osteoarthritis (OA).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 20, 2023
CompletedFirst Submitted
Initial submission to the registry
September 26, 2023
CompletedFirst Posted
Study publicly available on registry
October 3, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 2, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 2, 2024
CompletedAugust 6, 2024
August 1, 2024
7 months
September 26, 2023
August 5, 2024
Conditions
Outcome Measures
Primary Outcomes (5)
Knee Osteoarthritis Outcome Score (KOOS)
The KOOS is a questionnaire that assesses five aspects of knee injury and osteoarthritis: pain, symptoms, ADL function, sport and recreation function, and quality of life. Scores are transformed to a 0-100 scale, with zero representing extreme knee problems and 100 representing no knee problems. Higher scores indicate better function and less pain.
Baseline
Forward Step Down Test (FSDT)
This functional ability test requires participants to perform as many repetitions as possible in 30 seconds of a specific movement. The number of valid repetitions performed in this duration is recorded.
Baseline
Single Leg Hop Test (SLHT)
n this test, participants hop forward as far as possible on one leg, and the distance hopped is recorded.
Baseline
Isokinetic Testing Procedures
This procedure involves conducting tests of three (60°/s) or five (120°/s) maximal nonconsecutive efforts with specific rest intervals. Each subject is instructed to exert maximal effort throughout the whole range of motion.
Baseline
Rate of Force Development (RFD)
The RFD is a measure of the speed at which the force of a muscle contraction develops. It is typically measured during isometric contractions and provides information about the muscle's explosive strength capacity.
Baseline
Study Arms (2)
Knee OA Patients
This group consists of patients who have been diagnosed with knee osteoarthritis. They will be subjected to a series of tests to assess the maximal rate of force development of ankle muscles and their functional abilities.
Healthy Control
This group will include healthy individuals without knee osteoarthritis. They will undergo the same series of tests to serve as a control group, enabling the comparison of results with the Knee OA Patients group.
Interventions
This test is designed to measure the maximal rate of force development in the ankle muscles, specifically the plantar flexors. It aims to assess the relationship between the strength of these muscles and the functional ability in patients with knee osteoarthritis. The results from this test will help to understand how lower limb muscle strength influences the symptoms and progression of knee osteoarthritis.
Eligibility Criteria
Patients suffering from knee osteoarthritis.
You may qualify if:
- Group 1 (Knee OA group)
- Patients diagnosed with knee osteoarthritis according to Performance of the 2018 classification criteria for early stage knee OA was tested using data from the Osteoarthritis Initiative (OAI (Leung et al.,2020).
- Grade 2-3 KOA cases according to Kelgren-Lawrance classification
- Having knee pain for at least 6 months.
- The visual analog scale (VAS) score being at least 3 or more.
- Group 2 (Healthy control group) 1. Individuals with no signs or symptoms of Knee OA or other neurological or musculoskeletal conditions.
You may not qualify if:
- Patellar subluxation
- Surgery in any joint of the lower limb
- Meniscal injury
- Ligament instability
- Patients who received intra-articular injection in the knee in the last 6 months
- Patients with problems in the hip and ankle
- Patients who participated in in another physical therapy program in the last 3 months were not included in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Outpatient clinic of faculty of physical therapy, Ahram Canadian University
Al Ḩayy Ath Thāmin, Giza Governorate, 3221405, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Abeer Abdelrahman, Ph.D
Cairo University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Electromyography lab
Study Record Dates
First Submitted
September 26, 2023
First Posted
October 3, 2023
Study Start
July 20, 2023
Primary Completion
February 2, 2024
Study Completion
February 2, 2024
Last Updated
August 6, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share